Sumeet Bagadia's 3 Stocks to Buy Oct 13

Buy or Sell: Sumeet Bagadia's Top 3 Stocks to Buy on Monday, October 13, 2025

The Indian stock market continues its bullish stride, with benchmark indices like Nifty 50 and Sensex posting gains for the second consecutive session on Friday, October 10, 2025. Stocks to buy on Monday are in focus as Nifty crossed 25,300 intraday, its highest since mid-September, fueled by widespread sectoral buying except in metals. Closing at 25,285.35, up 0.41%, the index reflects renewed investor confidence amid positive economic cues. Broader markets mirrored this uptrend, with midcaps up 0.46% and smallcaps gaining 0.74%. Sectors like realty, healthcare, and pharma led with over 1.5% advances, signaling robust buy or sell stocks opportunities for the week ahead.

As markets eye further upside, Sumeet Bagadia, Executive Director at Choice Broking, shares insights on stocks to buy on Monday. With Nifty breaking key resistance at 25,300, Bagadia forecasts a push toward 25,800, albeit with a pause possible at 25,550. This technical breakout underscores improving sentiment, making selective buying in strong charts essential. His recommendations—SBI, BEL, and Dr. Reddy's Laboratories—highlight banking, defense, and pharma sectors poised for momentum, offering traders clear entry points, targets, and stop losses amid the ongoing rally in Indian equities.

Market Momentum Builds: Nifty's Breakout and Weekly Gains

Friday's session exemplified market resilience, with Sensex closing at 82,500.82, a 0.40% rise, and both indices logging 1.5% weekly advances. This buy or sell stocks environment stems from broad participation, as FMCG, auto, and banking sectors added 0.4-0.8%. Metals lagged due to global commodity pressures, but the overall tone remains optimistic, supported by strong domestic inflows and favorable monsoons boosting rural demand.

Bagadia notes the Nifty's decisive move above 25,300 as a pivotal shift, transforming prior resistance into support. This technical setup, backed by rising volumes, suggests sustained upside, with 25,800 as the next milestone. Traders scanning for stocks to buy on Monday should prioritize those showing bullish patterns like breakouts from trendlines or consolidations, ensuring alignment with broader market trends for minimized risks.

• Nifty resistance break: Signals potential 2-3% weekly gains if momentum holds.
• Sectoral leadership: Realty and pharma outperform, ideal for diversified portfolios.
• Broader indices: Mid and smallcaps' strength indicates inclusive growth.

Looking ahead, geopolitical stability and upcoming earnings could further propel buy or sell stocks decisions, with focus on fundamentally sound names exhibiting technical vigor.

SBI Stock Recommendation: Bullish Breakout Signals Strength

State Bank of India (SBI), a cornerstone of the banking sector, emerges as a prime candidate among stocks to buy on Monday at ₹880.65. After range-bound consolidation, the share price has shattered a falling trendline, accompanied by surging volumes that underscore fresh buying momentum. This pattern often precedes extended rallies in large-cap banks, especially with improving asset quality and loan growth.

Technically, SBI trades above key exponential moving averages (20, 50, and 200-day EMAs), cementing a bullish bias with these levels as robust supports. Near-term resistance at ₹890 beckons; a close above could accelerate toward ₹945. The Relative Strength Index (RSI) at 65.83 reinforces upward continuation without overbought risks, ideal for intraday or swing trades in this buy or sell stocks landscape.

• Entry point: ₹880.65, leveraging current consolidation breakout.
• Target: ₹945, based on measured move from recent highs.
• Stop loss: ₹868, protecting against downside reversals below supports.
• Volume surge: Confirms institutional interest in banking recovery.

Fundamentally, SBI's net interest margins and deposit growth position it well amid economic rebound, making it a reliable pick for portfolios eyeing 7-8% returns in the short term. Monitor banking index cues for amplified moves.

BEL Stock Recommendation: Cup and Handle Pattern Eyes Upside

Bharat Electronics Limited (BEL), a defense sector heavyweight, stands out as one of the stocks to buy on Monday at ₹413.50. The chart reveals a classic cup and handle formation, a bullish continuation pattern hinting at imminent breakout and near-term gains. Rising volumes alongside this setup indicate robust demand, particularly with government push on indigenization in defense manufacturing.

From a technical lens, BEL comfortably resides above its 20, 50, and 200-day EMAs, validating trend sustainability. The RSI at 61.03 on daily charts points to building momentum with headroom for further advances. A push beyond immediate resistance could ignite a rally toward ₹445, aligning with broader market positivity in PSU stocks.

• Entry: ₹413.50, capitalizing on pattern completion.
• Target: ₹445, projecting from handle's depth.
• Stop loss: ₹397, below cup's base for risk control.
• Pattern reliability: High success rate in trending markets like current.

BEL's order book expansion and export potential enhance its appeal in buy or sell stocks strategies, potentially yielding 7-10% in weeks if defense budgets align favorably. Pair with sector peers for balanced exposure.

Dr. Reddy's Laboratories: Symmetrical Triangle Signals Accumulation

Dr. Reddy's Laboratories (DRREDDY), a pharma bellwether, merits attention as stocks to buy on Monday at ₹1,264.40. The stock hovers near a symmetrical triangle apex, sustaining above prior swing lows amid accumulation phases. This consolidation often precedes directional moves, especially in healthcare's outperformance.

Technically, resistance at ₹1,270 looms; breaching it with volume could propel toward ₹1,355. Support at ₹1,230 offers a safety net, while RSI at 49.77 edges from oversold, hinting at bullish reversal. In the buy or sell stocks arena, this setup favors upside if global drug pricing stabilizes.

• Entry: ₹1,264.40, post-triangle confirmation.
• Target: ₹1,355, based on pattern projection.
• Stop loss: ₹1,220, guarding against breakdown.
• RSI breakout: Indicates momentum shift from neutral.

Dr. Reddy's robust pipeline and US market traction bolster fundamentals, positioning it for 6-8% gains. Watch pharma index for confluence in this volatile segment.

Technical Insights: Decoding Patterns for Buy or Sell Decisions

Bagadia's picks leverage proven technicals: trendline breaks for SBI signal reversals, cup and handle for BEL denotes continuations, and triangles for DRREDDY imply volatility contractions before expansions. These align with Nifty's ascent, emphasizing volume and RSI for validation in stocks to buy on Monday.

In broader context, EMAs provide dynamic supports, while stop losses mitigate drawdowns. For novices, these tools democratize buy or sell stocks trading, blending chart reading with risk management for consistent edges.

• Trendline break: Volume-confirmed for trend shifts.
• Cup and handle: Measures targets from handle length.
• Symmetrical triangle: Breakout direction dictates bias.
• RSI thresholds: 50+ for bulls, under 30 for oversold buys.

Integrating fundamentals like earnings growth enhances reliability, turning technical signals into high-conviction trades amid market uptrends.

Strategic Tips for Monday Trading

Approach October 13 with discipline: Scale into positions on pullbacks, trail stops on winners, and diversify across sectors. Bagadia advises monitoring 25,550 for Nifty pauses, using them for adding to strong names like these. In volatile sessions, prioritize liquidity to avoid slippage in buy or sell stocks executions.

Ultimately, these recommendations blend technical precision with market pulse, empowering investors to navigate the rally toward 25,800 confidently.